---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-016739"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2023-05-12T23:59:59+00:00"
generated_at: "2026-06-15T02:38:51.700489+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve conversion of preferred shares; outstanding common to increase ~44% to 2.3M

## Summary
- Special meeting on May 8, 2023: all four proposals passed, including conversion of Series C & D preferred into common.
- Convertible notes with £1.36M outstanding balance to convert into 1,149,273 Series C shares, effective May 9.
- Upon full conversion of Series C (3.5M shares) and Series D (176k shares), common outstanding will be ~2.29M (up from ~1.58M).
- 2019 Long Term Incentive Plan amended to increase authorized shares by 50,000 to 125,000 (Proposal 3 approved).
- All conversions are in process and deemed effective as of May 10, 2023.

## SEC filing metadata
- accession: 0001493152-23-016739
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2023-05-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.02, 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-016739
- JSON: https://secwatch.observer/filing/0001493152-23-016739.json
- Plain text: https://secwatch.observer/filing/0001493152-23-016739.txt

## Key facts
- Shareholder Votes
  INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve the full conversion of Series C Convertible Preferred Stock and the issuance of shares of Common Stock in connection with such conversion.
  - Outcome: passed
  source text: FOR AGAINST ABSTAIN 530,145 7,392 71,927
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm
- Shareholder Votes
  INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve an increase in the number of shares of Common Stock authorized for issuance under the 2019 Plan by 50,000 shares.
  - Proposal: equity plan
  - Outcome: passed
  source text: FOR AGAINST ABSTAIN 584,036 25,164 264
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm
- Shareholder Votes
  INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve the full conversion of Series D Convertible Preferred Stock and the issuance of shares of Common Stock in connection with such conversion.
  - Outcome: passed
  source text: FOR AGAINST ABSTAIN 585,379 23,657 428
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm
- Shareholder Votes
  INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies.
  - Outcome: passed
  source text: FOR AGAINST ABSTAIN 583,313 25,538 613
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.